MELA Sciences is a medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma ski... More >>
IRVINGTON, N.Y., May 6, 2013 /PRNewswire/ -- In recognition of Melanoma Monday® and National Melanoma/Skin Cancer Detection & Prevention Month™, MELA Sciences, Inc. (NASDAQ: MELA) visited the NASDAQ MarketSite in Times Square today to ring the Opening Bell and sponsor free skin cancer checks.
To view the multimedia assets associated with this release, please click:
IRVINGTON, N.Y., April 30, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed and is commercializing MelaFind®, today announced financial results for the first quarter ended March 31, 2013.
First Quarter 2013 Performance Highlights:
Ended the first twelve months of the MelaFind commercial launch with significant national distribution by having placements in 28 states in the US and 21 cities in Germany.
63% of US po...
FREE MELAFIND® SESSIONS ON MAY 1
IRVINGTON, N.Y., April 23, 2013 /PRNewswire/ -- MELA Sciences, Inc. (NASDAQ: MELA).
(Logo: http://photos.prnewswire.com/prnh/20130103/NY36051LOGO )
As part of its dedication to help reduce soaring melanoma rates in the United States, MELA Sciences, Inc. is sponsoring free MelaFind® examinations at participating dermatologist offices nationwide on May 1, the first day of Skin Cancer Detection and Prevention Month™.
"Despite advances in sun protection...